STAT+: Telehealth leapfrogs FDA approval with off-label GLP-1 prescriptions for addiction

T1Covered by 1 source · first reported by STAT News (health-tech) at 22 Oct, 08:30 UTC

As telehealth promotes GLP-1s for addiction, experts worry about fragmented care, and exposing patients to unknown risks.

science

Sources

• T1STAT+: Telehealth leapfrogs FDA approval with off-label GLP-1 prescriptions for addictionSTAT News (health-tech)22 Oct, 08:30